ABSTRACT
Arachidonic acid cytochrome P-450 (CYP) hydroxylase 4A isoforms, including 4A1, 4A2, 4A3 and 4A8 in the rat kidney, catalyze arachidonic acid to produce 19/20-Hydroxyeicosatetraenoic acids (20-HETE), a biologically active metabolite, which plays an important role in the regulation of blood pressure. However, controversial results have been reported regarding the exact role of 20-HETE on blood pressure. In the present study, we used recombinant adeno-associated viral vector (rAAV) to deliver CYP 4A1 cDNA and antisense 4A1 cDNA into Sprague-Dawley (SD) rats and spontaneously hypertensive rats (SHR), respectively, to investigate the effects of long-term modifications of blood pressure and the potential for gene therapy of hypertension. The mean systolic pressure increased by 14.2±2.5 mm Hg in rAAV·4A1-treated SD rats and decreased by 13.7±2.2 mm Hg in rAAV·anti4A1-treated SHR rats 5 weeks after the injection compared with controls and these changes in blood pressure were maintained until the experiments ended at 24 weeks. In 4A1 treated animals CYP4A was overexpressed in various tissues, but preferentially in the kidney at both mRNA and protein levels. In anti-4A1-treated SHR, CYP4A mRNA in various tissues was probed, especially in kidneys, but 4A1 protein expression was almost completely inhibited. These results suggest that arachidonic acid CYP hydroxylases contribute not only to the maintenance of normal blood pressure but also to the development of hypertension. rAAV-mediated anti4A administration strategy has the potential to be used as targeted gene therapy in human hypertension by blocking expression of CYP 4A in kidneys.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
McGiff JC, Quilley J . 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol Regul Integr Comp Physiol 1999; 277:R607–23.
Schwartzman ML, da Silva JL, Lin F, Nishimura M, Abraham NG . Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 1996; 73:652–63.
Schwartzman M, Carroll MA, Ibraham NG, et al. Renal arachidonic acid metabolism. The third pathway. Hypertension 1985; 7(3 Pt 2):I136–44.
Zeldin DC . Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001; 276:36059–62.
Makita K, Falck JR, Capdevila JH . Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. Faseb J 1996; 10:1456–63.
Ma YH, Schwartzman ML, Roman RJ . Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 1994; 267(2 Pt 2):R579–89.
Wilson TW, Alonso-Galicia M, Roman RJ . Effects of lipid-lowering agents in the Dahl salt-sensitive rat. Hypertension 1998; 31(1 Pt 2):225–31.
Roman RJ, Alonso-Galicia M, Wilson TW . Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens 1997; 10(5 Pt 2): S63–7.
Omata K, Abraham NG, Escalante B, Schwartzman ML . Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol Renal Physiol 1992; 262:F8–16.
Sacerdoti D, Abraham NG, McGiff JC, Schwartzman ML . Renal cytochrome P-450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats. Biochem Pharmacol. 1988; 37:521–7.
Su P, Kaushal KM, Kroetz DL . Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol Regul Integr Comp Physiol 1998; 275(2 Pt 2):R426–38.
Wang MH, Zand BA, Nasjletti A, Laniado-Schwartzman M . Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy. Am J Physiol Regul Integr Comp Physiol 2002; 282:R383–9.
Zhang F, Qian JQ, Wang DW . Arachidonate CYP hydroxylases of kidney contribute to formation of hypertension and maintenance of blood pressure. Acta Pharmacol Sin 2002; 23:497–502.
Wang DW, Zhang F, Qian JQ . Contribution of cytochrome P450 4a1 to the long term control of arterial blood pressure: evidence from somatic CYP 4a1 gene modidications. FASEB J 2002; 16:A486 (abstract).
Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, Laniado-Schwartzman M . CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol Regul Integr Comp Physiol 2001; 280:R255–261.
Kimura S Hardwick JP, Kozak CA, Gonzalez FJ . The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and identification of a conserved 19-bp upstream element. DNA 1989; 8:503–16.
Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72:2224–32.
Monahan PE, Samulski RJ . Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 2000; 6:433–40.
Xiao X, Li J, Samulski R . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70:8098–108.
Auricchio A, Hildinger M, O'Connor E, Gao GP, Wilson JM . Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther 2001; 12:71–6.
Wang J, Xiong W, Yang Z, et al. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23:236–43.
Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248–54.
Nguyen X, Wang MH, Reddy KM, Falck JR, Schwartzman ML . Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol Regul Integr Comp Physiol 1999; 276:R1691–700.
Wang MH, Wang J, Chang HH, et al. Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats. Am J Physiol Renal Physiol 2003; 285:F295–302.
Zou AP, Fleming JT, Falck JR, et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol Regul Integr Comp Physiol 1996; 270:R228–237.
Lange A, Gebremedhin D, Narayanan J, Harder D . 20-Hydroxyeicosatetraenoic Acid-induced Vasoconstriction and Inhibition of Potassium Current in Cerebral Vascular Smooth Muscle Is Dependent on Activation of Protein Kinase C. J Biol Chem 1997; 272:27345–52.
Imig JD, Zou AP, Stec DE, et al. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol Regul Integr Comp Physiol 1996; 270:R217–27.
Ito O, Alonso-Galicia M, Hopp KA, Roman RJ . Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol Renal Physiol 1998; 274:F395–404.
Escalante B, Erlij D, Falck JR, McGiff JC . Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 1991; 251:799–802.
Alonso-Galicia M, Frohlich B, Roman RJ . Induction of P4504A activity improves pressure-natriuresis in Dahl S rats. Hypertension 1998; 31(1 Pt 2):232–6.
Shatara RK, Quest DW, Wilson TW . Fenofibrate lowers blood pressure in two genetic models of hypertension. Can J Physiol Pharmacol 2000; 78:367–71.
Wang T, Li H, Zhao C, et al. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Ther 2004; 11:1342–50.
Gunzl A, Palfi Z, Bindereif A . Analysis of RNA–protein complexes by oligonucleotide-targeted RNase H digestion. Methods 2002; 26:162–9.
Zhao X, Imig JD . Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr Drug Metab 2003; 4:73–84.
Escalante BA, McGiff JC, Oyekan AO . Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule. Am J Physiol Renal Physiol 2002; 282:F144–150.
Carroll MA, Kemp R, Cheng MK, McGiff JC . Regulation of preglomerular microvascular 20-hydroxyeicosatetraenoic acid levels by salt depletion. Med Sci Monit 2001; 7:567–72.
Oyekan AO, McAward K, Conetta J, Rosenfeld L, McGiff JC . Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. Am J Physiol Regul Integr Comp Physiol 1999; 276(3 Pt 2):R766–75.
Acknowledgements
This project was supported by the National Natural Science Foundation of China (NSFC, No.39870307) and National Basic Research Program of China (973 Program, No. G2000056901). KC was the recipient of an Fonds de la recherche en santé du Québec (FRSQ, Quebec-Canada) - NSFC (China exchange grant).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
ZHANG, F., CHEN, C., QIAN, J. et al. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. Cell Res 15, 717–724 (2005). https://doi.org/10.1038/sj.cr.7290341
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/sj.cr.7290341
Keywords
This article is cited by
-
Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis
Nature Communications (2019)
-
Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury
BMC Genomics (2013)
-
The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector
Molecular Biology Reports (2013)
-
Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure
Kidney International (2009)
